Carolina Tarantino

Carolina Tarantino is a Researcher at the Institute for Bioengineering of Catalonia (IBEC), specializing in pluripotent stem cell research and organ regeneration. Her work focuses on advancing biomedical engineering applications, including kidney organoid development, biomaterials for tissue engineering, and disease modeling using stem cells. She is a core member of the 'Pluripotency for organ regeneration' research group, contributing to interdisciplinary projects at the intersection of bioengineering and medicine.

Her research interests emphasize translating fundamental discoveries into practical solutions, such as creating kidney organoids for disease modeling and drug testing, developing bioelectronic systems to monitor cardiomyocytes, and optimizing extracellular environments for stem cell differentiation. Key projects include exploring the role of CDK8/19 kinases in pluripotency maintenance and investigating the impact of diabetic conditions on SARS-CoV-2 susceptibility in kidney tissues.

Dr. Tarantino collaborates with institutions across disciplines, including the University of Barcelona and the Centro Nacional de Investigaciones Cardiovasculares (CNIC). Her publications demonstrate a strong focus on biomaterials, stem cell differentiation protocols, and organoid-based assays. She holds no formal awards listed but contributes significantly to scientific advancements through high-impact collaborative research.

Her work extends to preclinical applications, such as generating functional heart grafts from pluripotent stem cells and engineering skeletal muscle tissue for regenerative therapies. She actively participates in the 'Biomaterials for Regenerative Therapies' and 'Molecular Bionics' groups at IBEC, fostering innovation in bioengineering tools and molecular therapies.